Literature DB >> 23925626

BRAF V600E mutation and papillary thyroid cancer--in reply.

Mingzhao Xing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23925626      PMCID： PMC3804021          DOI： 10.1001/jama.2013.8598

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.

Authors:  Tae Hyuk Kim; Young Joo Park; Jung Ah Lim; Hwa Young Ahn; Eun Kyung Lee; You Jin Lee; Kyung Won Kim; Seo Kyung Hahn; Yeo Kyu Youn; Kwang Hyun Kim; Bo Youn Cho; Do Joon Park
Journal:  Cancer       Date:  2011-08-31       Impact factor: 6.860

2.  A piece of the puzzle: what does BRAF status mean in the management of patients with papillary thyroid carcinoma?

Authors:  David H Sarne
Journal:  J Clin Endocrinol Metab       Date:  2012-09       Impact factor: 5.958

3.  BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomas.

Authors:  Valentina Sancisi; Davide Nicoli; Moira Ragazzi; Simonetta Piana; Alessia Ciarrocchi
Journal:  J Clin Endocrinol Metab       Date:  2012-06-27       Impact factor: 5.958

Review 4.  Molecular pathogenesis and mechanisms of thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Nat Rev Cancer       Date:  2013-03       Impact factor: 60.716

5.  BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients.

Authors:  Yasuhiro Ito; Hiroshi Yoshida; Rie Maruo; Shinji Morita; Toru Takano; Mitsuyoshi Hirokawa; Tomonori Yabuta; Mitsuhiro Fukushima; Hiroyuki Inoue; Chisato Tomoda; Minoru Kihara; Takashi Uruno; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Akira Miyauchi
Journal:  Endocr J       Date:  2008-10-08       Impact factor: 2.349

Review 6.  BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications.

Authors:  Mingzhao Xing
Journal:  Endocr Rev       Date:  2007-10-16       Impact factor: 19.871
  6 in total
  1 in total

1.  Association of BRAFV600E mutation with clinicopathological features of papillary thyroid carcinoma: a study on a Chinese population.

Authors:  Shu Liu; Bingfei Zhang; Yanru Zhao; Pu Chen; Meiju Ji; Peng Hou; Bingyin Shi
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.